key: cord-0695755-iytfevzw authors: Quach, Ha-Linh; Hoang Thi, Ngoc-Anh; Khanh, Nguyen Cong; Thai, Pham Quang; Dinh, Phung Cong; Duong, Tran Nhu; Quynh Mai, Le Thi; Nghia, Ngu Duy; Tu, Tran Anh; Quang, La Ngoc; Quang, Tran Dai; Tai, Nguyen Trong; Vogt, Florian; Anh, Dang Duc title: Successful containment of a flight-imported COVID-19 outbreak through extensive contact tracing, systematic testing and mandatory quarantine: lessons from Vietnam date: 2021-05-26 journal: Travel Med Infect Dis DOI: 10.1016/j.tmaid.2021.102084 sha: 4c7738f5ad3acc68a96f4412afcc3fd15e5ec115 doc_id: 695755 cord_uid: iytfevzw BACKGROUND: The importation of SARS-CoV-2 through air travel poses substantial risks to generate new COVID-19 outbreaks. Timely contact tracing is particularly crucial to limit onwards transmission in settings without established community transmission. METHODS: We conducted an in-depth analysis of the response to a big flight-associated COVID-19 outbreak in Vietnam in March 2020 that involved contact tracing, systematic testing and strict quarantine up to third generation contacts. RESULTS: 183 primary contacts from the flight as well as 1,000 secondary and 311 third generation contacts were traced, tested, and quarantined across 15 provinces across Vietnam. The protracted confirmation of the index case at 3 days and 19 hours after arrival resulted in isolation/quarantine delays of 6.8 days (IQR 6.3–6.8) and 5.8 days (IQR 5.8–7.0) for primary and secondary cases, respectively, which generated 84.0 and 26.4 person-days of community exposure from primary and secondary cases, respectively. Nevertheless, only 5 secondary cases occurred. CONCLUSIONS: A large flight-related COVID-19 cluster was successfully contained through timely, systematic and comprehensive public health responses despite delayed index case identification. Multiagency collaboration and pre-established mechanisms are crucial for low and middle income countries like Vietnam to limit community transmission after COVID-19 importation through air travel. In March 2020, as the world began to experience the global spread of COVID-19, we detected a large 46 cluster of COVID-19 cases arising from a flight arriving from London, UK to Hanoi, Vietnam at 47 5.20am on March 2 (flight VN54). A 27-year-old business class passenger who was symptomatic 48 while on board and who tested positive for SARS-CoV-2 four days after arrival in Vietnam on 6 49 March was identified as index case. In-depth epidemiological investigations revealed in-flight 50 transmission during the 10 hours flight duration as the most likely route of transmission (1). 51 Until then, Vietnam had recorded three minor instances of COVID-19 importation through air travel 52 but no intensive contact tracing for passengers and their contacts was performed. Flight VN54 53 resulted in the first extensive case finding and contact tracing operations to prevent further 54 transmission in Vietnam. As contact tracing activities have been conducted to find potential exposed 55 passengers on flight with cases of H1N1, SARS, MERS, Tb, and measles, COVID-19 is certainly not 56 an exception for infectious disease on transportation. Mass transmission instances of COVID-19 on 57 flights had been explored and described in previous publications, however, the focus is limited to 58 transmission risk from infected individuals on the flight (2), with criteria of contact trace for 2 or 59 lesser seats from index case. While an infectious person, with an unpredicted novel disease, can still 60 transmit to larger scale of passengers on flight and also more contacts in local settings, contact tracing 61 should not stop at the current boundary of proximity, but to be tested its containment capacity at large. 62 Here we analyze epidemiological characteristics of the flight VN54 cluster and the subsequent 63 containment efforts undertaken among passengers, crew and their contacts to prevent further 64 transmission of SARS-CoV-2 in Vietnam. This work provides valuable information of how to contain 65 COVID-19 importation through air-travel successfully in a low-middle income setting. 66 Contact and case definitions 68 A case of COVID-19 was defined according to the Vietnam Ministry of Health guidelines in place at 69 the time of our investigation (3). All passengers and crew members on board VN54 flight were 70 considered as primary contacts of the index case. Secondary contacts were defined as persons who 71 had close contacts (≤ 2 meters for ≥ 15 minutes/ in the same closed space, e.g. house, workplace, 72 public transport, during the incubation period) with a primary contact between arrival of flight VN54 73 to Vietnam and start of isolation or quarantine. Third generation contacts were defined as non-close 74 contacts (> 2 meters apart/ in an open space during the incubation period) with a primary and/or a 75 secondary contact between arrival of flight VN54 to Vietnam and start of isolation or quarantine. 76 All traced primary contacts who could be reached were interviewed using a standard questionnaire 95 regarding their secondary and third generation contacts since arrival to Vietnam. In addition, they 96 were tested for SARS-CoV-2 and transferred to mandatory 14-day quarantine immediately at 97 centralized facilities, regardless of symptoms and test result. All flight passengers who had already 98 transited out of Vietnam were contacted through border health control authorities at their last 99 traceable destinations. Similar to primary contacts, secondary contacts were traced, tested for SARS-100 CoV-2, and systematically quarantined for 14 days in centralized facilities (at first). Third generation 101 contacts were asked by local health staffs to quarantine at home for 14 days, with daily symptom 102 monitoring by local health staffs. If their primary or secondary contact became a confirmed case, they 103 would be treated as secondary contacts, i.e. tested and transferred to centralized quarantine 104 immediately. 105 All persons in centralized quarantine had their symptoms and temperature checked twice daily, and in 106 addition to testing at start of quarantine, they also had oropharyngeal swabs collected after 3-5 days 107 and on day 13 before existing quarantine. Accommodation, meals, and basic hygiene necessities were 108 provided free of charge under the Ministry of Health's Mandatory Quarantine Scheme. Any person 109 showing COVID-19 symptoms, either at time of being successfully traced by local health staffs or at 110 any point during centralized or home quarantine, got immediately transferred to a reference hospital 111 for isolation and monitoring, as did anyone who got tested positive. Details of contact tracing and 112 testing strategy can be found in Figure 2 . In response to the increased testing needs resulting from the response to flight VN54, SARS-CoV-2 116 RT-PCR laboratory testing capacity was quickly scaled up in Vietnam (4). From relatively limited and 117 J o u r n a l P r e -p r o o f centralized testing capacities, within 10 days, over thirty local CDCs and all tertiary level hospitals 118 were enabled to handle up to 1,500 tests per day. Similarly, ICU capacity and isolation wards were 119 ramped up in all provincial health facilities, and military-run bases, dormitories, and hotels were 120 repurposed as centralized quarantine facilities. At designated COVID-19 hospitals, infection control 121 measures were strengthened, including strict visitor controls, triage of patients with pneumonia or 122 other symptoms of respiratory infection, hand hygiene and mask wearing requirements, and 123 maintenance of strict infection control practices with personal protective equipment. Healthcare 124 workers at these designated hospitals were required to avoid non-essential travel outside of hospitals. 125 All confirmed COVID-19 cases were isolated in designated COVID-19 hospitals, and received 126 treatment free-of-charge until confirmation of SARS-CoV-2 clearance as per Vietnam Ministry of 127 Health's criteria. 128 Since mid-January, the Government of Vietnam implemented temperature screening for all 130 international passengers (air and land) arriving in Vietnam. At the time of flight VN54, all passengers 131 with a history of travel to Mainland China, Hong Kong, Taiwan (from 1 February), South Korea 132 (from 24 February), Iran and Italy (from 28 February) had to undergo compulsory SARS-CoV-2 133 testing and quarantine. There was no requirement to wear masks on board commercial flights at that 134 time. Since VN54 departed in the UK, which was not covered by this policy at that time, none of its 135 passengers got tested and/or quarantined upon arrival. 136 At time of arrival of flight VN54, targeted lock-downs around locations with confirmed COVID-19 138 cases, such as hospital wards, resident buildings, hotels, etc. were the population-level method of 139 choice in response to a newly confirmed cases. In addition, anonymized information about newly 140 confirmed COVID-19 cases and newly identified clusters were shared publicly through mass media 141 and official governmental websites by NSCPC. Once the index case on flight VN54 got confirmed, 142 official messages calling for all passengers and crew members on that flight to seek medical services 143 were broadcasted daily on mass media nationwide. Regular hand washing, mask wearing, and social 144 distancing was encouraged. At the same time the NSCPC monitored the media landscape for 145 misinformation. Schools and universities in Vietnam were already closed since February, and mass 146 gatherings were mostly canceled. At most workplaces, temperature screening, health and international 147 travel history monitoring was already in place. Mask wearing policies were turned from mandatory 148 for high-risk workers (healthcare workers, essential workers) into mandatory in public places (5). 149 Ethics 150 This analysis was approved and exempted for ethics by the National Institute of Hygiene as a part of 151 national COVID-19 outbreak investigation and response activities. 152 A total of 16 crew members and 201 passengers were on board flight VN54, with 71.6% (n=144) of 154 passengers being foreigners, while 93.7% (n=15) of crew members were Vietnamese (Table 1) . 155 Contact tracing for primary contacts of the flight was completed on March 10 (eight days after the 156 flight arrival; four days after contact tracing initiation). All of the 167 (83.1%) passengers and the 16 157 (100%) crew members who were still in the country at that time were successfully traced. The 158 remaining 33 passengers transited to other countries (Table 1) . 159 Table 1 is about here 160 By March 13 (11 days after arrival; seven days after contact tracing initiation), we had identified a 161 total of 1,000 secondary contacts, who were all placed into centralized quarantine facilities, and 311 162 third generation contacts, who were asked to self-quarantine at their homes for 14 days. 163 Tracing activities for primary, secondary, and third generation contacts is illustrated in Figure 3 . The 164 majority of primary and secondary contacts were traced and quarantined/isolated four to five days 165 after the index case confirmation. For primary contacts, the median duration from flight arrival to start 166 of quarantine was 5.8 days (IQR 4.8 -6.8), while the median time from index case confirmation to 167 start of quarantine was 2.0 days (IQR 1.0 -3.0) ( Table 2 ). These data were not available for 168 secondary and third generation contacts. 169 Among primary contacts, we identified 15 primary COVID-19 cases in addition to the index case, of 171 which 14 were passengers and 1 was a crew member. One of the passenger cases had already transited 172 to Cambodia, where she was identified, tested, and confirmed by the Cambodia Center of Disease 173 Control. On-board transmission during the 10-hour flight duration was found to have been the most 174 likely route of transmission for these primary cases (1). Subsequently, five secondary cases emerged 175 among secondary contacts of four primary cases. Of these, three were family members of primary 176 cases, one was a local tourist operator and one was a saleswoman who had contact with primary cases. 177 No third generation cases were reported. 178 Figure 4 and Table 2 shows the temporal sequence of exposure, symptom onset and isolation for 179 primary and secondary cases. The index case, who was symptomatic during the flight, presented at a 180 health facility in Hanoi on 5 March (three days after landing) and received a nasopharyngeal swab. 181 The laboratory test result was reported positive at 11pm the same day (5 March), and the index case 182 was immediately isolated (3 days and 19 hours after arrival). Contact tracing was only started the 183 following morning at 8 am on 6 March (4 days and 3 hours after arrival of the flight). 184 Consequently, for primary cases, the median duration between last exposure (arrival of the flight) and 185 start of isolation/quarantine was 6.8 days (IQR 6.3 -6.8), of which the delay from index case 186 confirmation to isolation/quarantine was 3.0 days (IQR 2.5 -3.0). The equivalent delays for 187 secondary cases were 5.8 days (IQR 5.8 -7.0) (from last exposure to their epi-linked primary cases) 188 and 2.0 days (IQR 2.0 -5.1), respectively (Table 2) The case finding and contact tracing activities that followed occurred almost simultaneously, which 230 required the close cooperation of local government authorities and health agencies from all provinces 231 around the country. During the course of four days, contact tracing reached all passengers and crew 232 members who remained in Vietnam at time of investigation (168 of passengers and 16 crew 233 members). Concurrently, after seven days of intensive contact tracing, we had placed into quarantine 234 over 1,300 secondary contacts, among who we identified five additional secondary cases, which 235 corresponds to seven secondary contacts per primary contact and about 87.4 contacts per case. This is 236 higher than the contact-per-case ratios estimated in a study from Singapore (30.8 ratio) (6) transmission occurs before symptom onset in the index case (22). As a result, asymptomatic testing is 278 increasingly recommended around the world to ensure the sensitivity and timeliness of case 279 confirmation (23-25), and 14-day isolation is required in many countries for cases and high-risk 280 contacts (26,27). In Vietnam, rigorous contact tracing, frequent testing and systematic quarantine 281 guaranteed a highly sensitive approach and allowed us to timely and effectively identify all case 282 associated with flight VN54. However, as all cases were detected through contact-based surveillance, 283 the average delay from exposure to isolation for primary cases in this study (6.8 days) was higher than 284 those of similar mode of detection and similar to those of symptom-based surveillance (28). Among 285 those who were symptomatic before quarantine/isolation, the observed 6.3 days of delay in admission 286 in our study were also higher than the delay from onset to admission observed in Mainland China 287 (average 4.9 days for travelers) (28), and in Hong Kong (2.6 -4.2 days for imported cases) (29). This 288 may be explained by the delay in the initial confirmation of the index case as explained above. Longer 289 delays for successful contact tracing and isolation/quarantine was also observed for primary cases 290 than for secondary cases, which in our study was due to the fact that three out of five secondary cases 291 were direct epi-linked to the index case of the flight, who were very quickly identified and isolated. 292 The remaining two secondary cases were isolated only five days after exposure to their primary cases, 293 and two days after their primary case confirmation (Figure 4) . 294 The analysis of our response efforts offers a number of lessons learnt for future outbreaks in similar 295 settings: contact tracing and case findings activities require timeliness, equipped staffs and prepared 296 facilities (30,31). Indeed, the organizational resources and structures needed for public health 297 measures at national scale in response to the flight VN54 cluster were required and utilized for the 298 first time in Vietnam. Required facilities included quick available passenger's information, consistent 299 and rapid communication means for internal uses and public uses, testing and quarantine facilities was 300 J o u r n a l P r e -p r o o f mobilized to help multi-agency staffs to conduct an effectively exhaustive contact tracing effort. 301 Many studies showed the challenges to access data and mobilize resources in complex multi-302 jurisdictional contexts (31,32). The flow of passenger data from airlines to public-health agencies can 303 easily be delayed since many airlines do not share these data willingly, and many public health 304 agencies do not have the authority to access such information on time (33, 34) . In addition, a broken 305 feedback loop of information across health jurisdictions for national-wide contact tracing can also 306 quickly stagnant the contact tracing process. One study from the US CDC's airport quarantine stations 307 showed incomplete information gathered from local health agencies during a TB outbreak rendered it 308 difficult to indicate whether potential contacts were found or tested (35). Another study from 309 Germany showed that completeness of information for passengers on board is crucial to improve a 310 comprehensive international contact tracing process, coupled with health education for passengers 311 about infectious disease transmission on public transport (36). In Vietnam, even though the process 312 was newly introduced and not yet tested in a simulation exercise, passenger information was obtained 313 and distributed during the first day of the outbreak response, which greatly enhanced the process of 314 subsequent contact tracing. Although complete information was not available from all passengers 315 since passengers did not have to disclose their address in Vietnam upon arrival, national cooperation 316 and support from local authorities, tourism and police departments ensured effectively tracing of all 317 passengers who remained in Vietnam at the time contact tracing was initiated. Additionally, clear and 318 sensitive inclusion criteria for contact tracing are crucial. The facts that we applied a blanket 319 definition of primary contacts to all passengers and crew members on flight VN54 was novel to 320 traditional public health measures for COVID-19 at time of investigation. Before VN54, there was 321 three instances of non-quarantined imported cases detected in Vietnam, however, investigation was 322 scoped at close contacts in community, and to passengers within two seats away from index case. 323 Following the approach of "To miss one case is to ignite two others", this cluster containment effort 324 showed that it is possible to quickly contain a highly infectious pathogen such as SARS-CoV-2 325 through national collective efforts and multi-agency. The delays inherent to case finding measures 326 such as testing, tracing and quarantine/isolation highlight the need for rapid adaptation of response 327 mechanisms in public health emergencies. While the delay in the detection of the index case could 328 have been shortened by systematic obligatory testing at arrival, contact tracing initiation could have 329 been accelerated by pre-established and pre-tested standard operating procedures to trigger immediate 330 activation of public health response following laboratory confirmation. Lessons were learnt quickly in 331 Vietnam. For example, as a result of the difficulties experienced to trace highly-mobile tourists across 332 the country, as soon as from 6 March onwards all inbound passengers were required to fill out health 333 declaration forms that included passengers' contact information in Vietnam. Soon thereafter, starting 334 on 21 March, mandatory SARS-CoV-2 testing and quarantine was implemented for all passengers 335 arriving in Vietnam regardless of their origin, which in turn greatly reduced contact tracing efforts and 336 resources for provincial health jurisdictions. To justify the need for the extensive contact tracing and 337 J o u r n a l P r e -p r o o f testing regime as implemented in our study, appropriate resources and training as well as a good 338 understanding of the local context of the COVID-19 situation is needed. 339 Our analysis had several limitations. The VN54 cluster was an early event during the COVID-19 340 epidemic in Vietnam after nearly a month of no new confirmed cases nationwide. Hence, a lot of 341 information was missing due to the lack of standard data collection and reporting at that time. We 342 lacked individual-level data about secondary and third generation contacts, including demographics, 343 type and location of exposure, date of quarantine for each individual, number of secondary and third 344 generation contacts per epi-linked primary contacts, and unsuccessfully traced contacts. Such data 345 would have allowed us an in-depth analysis of contact behaviors and to assess differences in risks of 346 infection. 347 The longer the ongoing pandemic lasts, the less sustained border control measures such as total border 348 closures or blanket quarantine policies may be practical and acceptable. Vietnam, as many countries, 349 is now considering to resume commercial air travel despite considerable risk of disease importation 350 and very low in-country transmission. Sustainable and flexible surveillance and contact tracing system 351 is crucial to adapt to the ever-changing situation, and to achieve a balance between containing disease 352 spread while reducing the overall health and socioeconomic impact due to COVID-19. Evidence 443 for transmission of covid-19 prior to symptom onset Surveillance and Containment Measures for the First 100 Patients with COVID-19 in 446 MMWR Morb Mortal Wkly Rep Estimation of 450 the asymptomatic ratio of novel coronavirus infections (COVID-19) China: An epidemiological investigation COVID-19: A rapid systematic review and meta-analysis of observational research The incubation period of 461 coronavirus disease 2019 (CoVID-19) from publicly reported confirmed cases: Estimation and 462 application of Novel Coronavirus-Infected Pneumonia All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research Declarations Travel Medicine and Infectious Disease requires that all authors sign a declaration of conflicting interests. If you have nothing to declare in any of these categories then this should be stated. A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research Declarations Travel Medicine and Infectious Disease requires that all authors sign a declaration of conflicting interests. If you have nothing to declare in any of these categories then this should be stated. A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research Signature (a scanned signature is acceptable, Print name but each author must sign) Declarations Travel Medicine and Infectious Disease requires that all authors sign a declaration of conflicting interests. If you have nothing to declare in any of these categories then this should be stated. A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. There is no funding for this research Signature (a scanned signature is acceptable, Print name but each author must sign) Declarations Travel Medicine and Infectious Disease requires that all authors sign a declaration of conflicting interests. If you have nothing to declare in any of these categories then this should be stated. A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated. Declarations Travel Medicine and Infectious Disease requires that all authors sign a declaration of conflicting interests. If you have nothing to declare in any of these categories then this should be stated. A conflicting interest exists when professional judgement concerning a primary interest (such as patient's welfare or the validity of research) may be influenced by a secondary interest (such as financial gain or personal rivalry). It may arise for the authors when they have financial interest that may influence their interpretation of their results or those of others. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. All sources of funding should also be acknowledged and you should declare any involvement of study sponsors in the study design; collection, analysis and interpretation of data; the writing of the manuscript; the decision to submit the manuscript for publication. If the study sponsors had no such involvement, this should be stated.